Zobrazeno 1 - 10
of 144
pro vyhledávání: '"aicda"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
UnAIDed Class Switching in Activated B-Cells Reveals Intrinsic Features of a Self-Cleaving IgH Locus
Autor:
Iman Dalloul, Brice Laffleur, Zeinab Dalloul, Batoul Wehbi, Florence Jouan, Baptiste Brauge, Paco Derouault, Jeanne Moreau, Sven Kracker, Alain Fischer, Anne Durandy, Sandrine Le Noir, Michel Cogné
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Activation-induced deaminase (AID) is the major actor of immunoglobulin (Ig) gene diversification in germinal center B-cells. From its first description, it was considered as mandatory for class switch recombination (CSR), and this discovery initiate
Externí odkaz:
https://doaj.org/article/1d9f8414d03043ce9311e61b783fb76a
Autor:
Paolo Casali, Tian Shen, Yijiang Xu, Zhifang Qiu, Daniel P. Chupp, John Im, Zhenming Xu, Hong Zan
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Estrogen contributes to females' strong antibody response to microbial vaccines and proneness to autoimmunity, particularly antibody-mediated systemic autoimmunity, in females. We have hypothesized that this is due to estrogen-mediated potentiation o
Externí odkaz:
https://doaj.org/article/081b835f52e44e3a80823d824d407a34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Burkitkan Akbay, Diego Germini, Amangeldy K. Bissenbaev, Yana R. Musinova, Evgeny V. Sheval, Yegor Vassetzky, Svetlana Dokudovskaya
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4, p 1588 (2021)
HIV-1 infects T cells, but the most frequent AIDS-related lymphomas are of B-cell origin. Molecular mechanisms of HIV-1-induced oncogenic transformation of B cells remain largely unknown. HIV-1 Tat protein may participate in this process by penetrati
Externí odkaz:
https://doaj.org/article/8550d964d236436694c4ffe72a0485a8
Autor:
Yunxiang Mu, Kevin M. McBride
Publikováno v:
Molecular & Cellular Oncology, Vol 5, Iss 5 (2018)
The mutations induced by activation-induced cytidine deaminase (AID) trigger antibody diversification but can cause genome instability. We find that AID phosphorylation is an important determinant of “off-target” mutagenesis and identify a drug t
Externí odkaz:
https://doaj.org/article/9a66c05828d644f79f5074a1b51753a2
Autor:
Maria Pia Cicalese, Jolanda Gerosa, Manuela Baronio, Davide Montin, Francesco Licciardi, Annarosa Soresina, Rosa Maria Dellepiane, Maurizio Miano, Lucia Augusta Baselli, Stefano Volpi, Carlo Dufour, Alessandro Plebani, Alessandro Aiuti, Vassilios Lougaris, Georgia Fousteri
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Mutations in genes that control class switch recombination and somatic hypermutation during the germinal center (GC) response can cause diverse immune dysfunctions. In particular, mutations in CD40LG, CD40, AICDA, or UNG cause hyper-IgM (HIGM) syndro
Externí odkaz:
https://doaj.org/article/d31e6288c914441486635ff1670779a9
Autor:
Brad G. Magor
Publikováno v:
Biology, Vol 4, Iss 3, Pp 512-524 (2015)
It has long been believed that fish lack antibody affinity maturation, in part because they were thought to lack germinal centers. Recent research done on sharks and bony fishes indicates that these early vertebrates are able to affinity mature their
Externí odkaz:
https://doaj.org/article/b624c79c76324c8dbb177eaa9592fa34
Autor:
Guttormsen, Ida
Publikováno v:
Guttormsen, Ida. The effects of vitamin A in B cells from patients with the immunodeficiency disorder CVID. Master thesis, University of Oslo, 2018
Externí odkaz:
http://hdl.handle.net/10852/63343
https://www.duo.uio.no/bitstream/handle/10852/63343/1/Master-thesis-Ida-Guttormsen.pdf
https://www.duo.uio.no/bitstream/handle/10852/63343/1/Master-thesis-Ida-Guttormsen.pdf
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2940
Background: Acquired resistance after EGFR-tyrosine kinase inhibitor (TKI) treatment is the rule rather than the exception. Overcoming resistance to EGFR-TKIs is essential if we are to develop better therapeutic strategies for lung cancer patients. H